MODIFICATION
66 -- Transconductance Amplifiers
- Notice Date
- 8/23/2009
- Notice Type
- Modification/Amendment
- NAICS
- 334515
— Instrument Manufacturing for Measuring and Testing Electricity and Electrical Signals
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- 1059444P
- Archive Date
- 9/17/2009
- Point of Contact
- William T. Lee, Phone: 3014435863, Doreen Williams, Fax: 301-827-7106
- E-Mail Address
-
william.lee@fda.hhs.gov, doreen.williams@fda.hhs.gov
(william.lee@fda.hhs.gov, doreen.williams@fda.hhs.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR 12.6, simplified acquisition procedures and the resultant purchase order will include all applicable provisions and clauses in effect through the Federal Acquisition Circular 05-35. This solicitation is issued as a Request for Proposal (RFQ). This announcement constitutes the only solicitation and a written solicitation will not be issued. This synopsis, NAICS code 334515, is to notify contractors that the government intends to issue a Purchase Order in accordance with FAR Part 13.106 for the following specifications, under the simplified acquisition procedures. This solicitation is posted 100% Total Small Businesses and will be awarded as a Firm Fixed Price Purchase Order. Prospective offerors are responsible for downloading the solicitation and any amendments. It is the offeror's responsibility to monitor the FedBizOpps website for the release of any amendments to this solicitation. The Government reserves the right to award a contract without discussions if the Contracting Officer determines that the initial offer(s) is/are providing the Best Value and discussions are not necessary. The Center for Devices and Radiological Health (CDRH) is in need of a contractor to design, develop and deliver two identical Transconductance Amplifier units for research purposes in order to study the electrophysiology of defibrillation waveform, duration, and shape; and evaluate these properties effect on efficacy of defibrillation success. The Transconductance Amplifier will be used to amplify an arbitrary input control waveform to a high current waveform having the same shape and duration as the original voltage control waveform. The amplified arbitrary waveform will be used on excised animal hearts, and will therefore need to be of sufficient voltage and current for successful defibrillation. See Figure 1 below. The input control waveform (±5V) will be amplified by a factor of 1 Amp per Volt to produce the output waveform. The Contractor shall be required to: a. Design, build and deliver two identical Transconductance Amplifiers with the following technical specifications: 1. The gain of the Transconductance Amplifier shall be 1 Amp per Volt. 2. The Bipolar Output Terminals shall be isolated from ground with a safety disconnect implemented as an electromechanical relay or equivalent. 3. The maximum output voltage range, referenced to the negative Bipolar Output Terminal, shall be -190 Volts to +190 Volts. 4. The maximum output current shall vary with the load resistance: a. For load resistances from 0 to 38 Ohms the maximum current output shall be limited to 5 Amps. b. For load resistances greater than 38 Ohms the maximum current output shall be 190 Volts divided by the load resistance. 5. Within the specifications for maximum output current (Specification 4) the current output shall follow the voltage input with a tolerance of ± 2%. 6. Duration of output waveform at 5A: 500ms or more. 7. Minimum number of 5A, square wave pulses, output per minute into a 38 Ohm load (by duration of pulse): 500 at 10ms, 50 at 100 ms, 10 at 500ms 8. The Bandwidth of the Transconductance Amplifier shall be DC to 1 kHz, or more. 9. A BNC Analog Output for monitoring the voltage output of the Transconductance Amplifier. The monitor voltage shall be a linear representation of the voltage on the Bipolar Output Terminals: +5 Volts shall represent +190 Volts and -5 Volts shall represent -190 Volts. 10. A BNC Analog Output for monitoring the current output of the Transconductance Amplifier. The monitor voltage shall be a linear representation of the voltage on the Bipolar Output Terminals: +5 Volts shall represent +5 Amps and -5 Volts shall represent -5 Amps. 11. A BNC Digital Input connection to enable the output of device. The Bipolar Output Terminals of the device shall be disconnected from the amplifier unless this enable line goes to a TTL logic low, engaging the electromechanical relays (see specification 2) and connecting the Bipolar Output Terminals to the amplifier. 12. A BNC Analog Input connector for arbitrary control waveforms (±5V) to be amplified. The input impedance shall be ≥ 5,000 Ohms. 13. Operation from AC power 110 volts, 50/60 Hz. 14. Indicators for proper functioning of the Transconductance Amplifier. 15. One year of technical support on use and troubleshooting of the HPA via both phone and email. 16. One year warranty covering repairs for defects in parts and workmanship. The vendor agrees to accept shipment of the units for repair if necessary. Deliverables may include: User’s manual, including schematics of the Transconductance Amplifier and all accessories and cables necessary for operation (excluding PC interfacing accessories).. FOB: Destination DELIVERY SCHEDULE: No later than 6 months after award DELIVERY LOCATION: CDRH 10903 New Hampshire Avenue, Bldg 62, Room 1120 Silver Spring, MD 20903 EVALUATION AND AWARD: The Government intends to evaluate proposals however; the Government reserves the right to award a contract without discussions if the Contracting Officer determines that the initial offer(s) is/are providing the Best Value and discussions are not necessary. The award will be made to the offeror whose proposal conforms to the terms and conditions of the solicitation under a Firm Fixed Price Purchase Order. Evaluation for Award: The award will be made to the party whose quote offers the best value to the government, technical and price. The Government may award this purchase order to other than the lowest priced technically acceptable quote. The Government will evaluate information based on the following evaluation criteria: 1) Technical Capability factor “Meeting or Exceeding the Technical Requirements”; 2) Price of product. Meeting the Technical Requirements is significantly more important than price. The FDA intends to make an award immediately after the response of this notice. The award will be made in accordance with FAR Part 13, Simplified Acquisition Procedures. CCR: Vendors must be registered in the Central Contractor Register (CCR) prior to the award of a contract. You may register by going to www.ccr.gov. You will need your Dun & Bradstreet number and banking information. QUESTIONS DEADLINE: All questions are to be submitted via email to: william.lee@fda.hhs.gov no later than August 24, 2009, 4:30 p.m. EST. QUOTATIONS DUE: All quotations are due, via email to: william.lee@fda.hhs.gov, no later than September 2, 2009, 4:30 p.m. EST.. No phone calls will be accepted. PROVISIONS and CLAUSES: The provision at FAR 52.212-1, Instructions to Offerors Commercial Items applies to this solicitation. Offerors shall include a completed copy of the provision at FAR 52.212-3, Offeror Representations and Certifications Commercial Items. The clause at FAR 52.212-4, Contract Terms and Conditions, Commercial Items applies to this acquisition. The clause at FAR 52.212-5 Contract Terms and Conditions Required to Implement Statues or Executive Orders, Commercial Items applies to this acquisition. The following FAR clauses cited are applicable: FAR 52.217-8, FAR 52.222-26, FAR 52.222-35, FAR 52.222-36, and FAR 52.232-33. FAR 52.217-9. Clauses and provisions are incorporated by reference and apply to this acquisition.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/1059444P/listing.html)
- Record
- SN01923035-W 20090825/090823233054-4c6ea824aba35a043f62e59043a4fd75 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |